PATENT CLAIM ANALYSIS

Application Number: 15776927
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "404000"]

Abstract:
The disclosure generally relates to a therapeutic approach based on the stimulation of resolution of inflammation by the Formyl-Peptide Receptor 2/Lipoxin A 4  receptor (FPR2/ALX) for the treatment of heart disease.

Claim (Index 4):
The method of  claim 1  wherein the treatment is associated with chronic heart failure.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.13333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13681496', '15656766', '14196047', '15490127', '14905768']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7564846102174956
- 35 USC 102 Novelty (BERT): 0.5166696547219203
- Combined Prediction Score: 0.7325031146679382
- Mean Citation Score: 187.28120400000003
- Max Citation Score: 217.76012000000003
- Similarity Product: 115.47915673040391

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test